HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

IPD-196

phosphatidylinositol 3-kinase inhibitor; structure in first source

Also Known As:

ethyl-6-(5-(2,4-difluorophenylsulfonamido)pyridin-3-yl)imidazo(1,2-a)pyridine-3-carboxylate

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Nicotinic Acids: 13
      - IPD-196: 1
- Heterocyclic Acids
  - Nicotinic Acids: 13
    - IPD-196: 1

Experts

1.	Hong, Soon-Sun: 1 article (02/2013)
2.	Hong, Sungwoo: 1 article (02/2013)
3.	Jeong, Yujeong: 1 article (02/2013)
4.	Jung, Kyung Hee: 1 article (02/2013)
5.	Lee, Hyunseung: 1 article (02/2013)
6.	Lee, Ju-Hee: 1 article (02/2013)
7.	Yan, Hong Hua: 1 article (02/2013)
8.	Yun, Sun-Mi: 1 article (02/2013)

Related Diseases

1.

Hepatocellular Carcinoma (Hepatoma)

02/01/2013 - "In this study we synthesized a novel PI3Kα inhibitor, IPD-196 [ethyl 6-(5-(2,4-difluorophenylsulfonamido)pyridin-3-yl)imidazo[1,2-a]pyridine-3-carboxylate], and evaluated its anticancer effects on human hepatocellular carcinoma (HCC) cells. "
02/01/2013 - "IPD-196, a novel phosphatidylinositol 3-kinase inhibitor with potent anticancer activity against hepatocellular carcinoma."

Related Drugs and Biologics

1.	pyridine
2.	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)